go back

Leukemia Gene Test For Treatment Planning

Vermont rates for HCPCS 81245

This laboratory analysis looks for a specific genetic change in a gene linked to acute myeloid leukemia, where an extra duplicated segment of the gene appears. Finding this change provides important information about prognosis and can help guide the choice of targeted treatment. The test is typically performed on a blood or bone marrow sample at diagnosis.

Rates data updated July 2026.

Facilitymedian $331 · 10th–90th $166$3800%20%10th90th$331Professionalmedian $100 · 10th–90th $79$1660%20%40%10th90th$100$100.0$200.0$500.0$1.0K

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Small sample; interpret with caution. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Professional
Modifier
Global
Typical Low
$79.43
Median
$79.43
Typical High
$114.82
BCBS
Setting
Facility
Modifier
Global
Typical Low
$331.13
Median
$331.13
Typical High
$338.84
Cigna
Setting
Facility
Modifier
Global
Typical Low
$275.42
Median
$380.19
Typical High
$380.19
Cigna
Setting
Professional
Modifier
Global
Typical Low
$165.96
Median
$199.53
Typical High
$371.54
MVP Health Care
Setting
Facility
Modifier
Global
Typical Low
$165.96
Median
$165.96
Typical High
$165.96
MVP Health Care
Setting
Professional
Modifier
Global
Typical Low
$165.96
Median
$165.96
Typical High
$165.96
United
Setting
Professional
Modifier
Global
Typical Low
$100.00
Median
$190.55
Typical High
$363.08